T2D Management Among a Community Clinic Patient Sample After California's May 2022 Medicaid Expansion
Authors' conclusion
T2D management improved among both undocumented and documented patients after Medi-Cal expansion.
Study context
- Population
- Undocumented and documented patients with T2D at two community clinics in Los Angeles County, May 1, 2021 to June 29, 2023; mean age 61.1 years, 65.1% female, 80.9% Latino
- Participants
- 14,028 encounters
- Exposure
- After vs before May 2022 Medi-Cal expansion; undocumented vs documented patients
- Outcome
- HbA1c and BMI, change pre/post May 2022
Methodological detailspre/post policy comparison, generalized linear mixed models, two community clinics
- Pre/post policy comparison
- Generalized linear mixed models
- Two community clinics
Main finding
As reported in the abstract
Haemoglobin A1c (HbA1c) decline across all encounters
points 0.22
95% CI −0.27, −0.18
Body mass index (BMI) decline
points 0.15
95% CI −0.21, −0.10
Observational data: associations, not effects.
Further findings
HbA1c and BMI by treatment status (new T2D medications) · after policy
- Patients on new medications had bigger drops in HbA1c and BMI than those not on them; did not vary by immigration status
Original publication
T2D Management Among a Community Clinic Patient Sample After California's May 2022 Medicaid Expansion. Diabetes Obes Metab. Published 15 June 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →